Stephanie Morrissey

600 total citations
12 papers, 431 citations indexed

About

Stephanie Morrissey is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Stephanie Morrissey has authored 12 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Stephanie Morrissey's work include Renal cell carcinoma treatment (5 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Stephanie Morrissey is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Stephanie Morrissey collaborates with scholars based in United States, Spain and United Kingdom. Stephanie Morrissey's co-authors include Ursula A. Matulonis, Alexi A. Wright, Panagiotis A. Konstantinopoulos, Susana M. Campos, Joyce F. Liu, Neil S. Horowitz, Jonathan E. Rosenberg, Roxanne Quinn, Carolyn Krasner and Toni K. Choueiri and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Gynecologic Oncology.

In The Last Decade

Stephanie Morrissey

10 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie Morrissey United States 8 186 185 141 128 72 12 431
C O'Flaherty United States 6 127 0.7× 187 1.0× 90 0.6× 117 0.9× 149 2.1× 8 430
Christopher DiSimone United States 6 114 0.6× 271 1.5× 148 1.0× 71 0.6× 133 1.8× 10 490
Domenico Priolo Italy 6 92 0.5× 169 0.9× 59 0.4× 97 0.8× 169 2.3× 9 364
Yasmine Baca United States 10 94 0.5× 174 0.9× 83 0.6× 51 0.4× 40 0.6× 56 292
L. Cannella Italy 9 70 0.4× 143 0.8× 69 0.5× 77 0.6× 55 0.8× 26 276
S. Loibl Germany 10 93 0.5× 254 1.4× 123 0.9× 146 1.1× 227 3.2× 30 516
Josep M. del Campo Spain 10 131 0.7× 187 1.0× 78 0.6× 62 0.5× 261 3.6× 20 439
Angeles A. Alvarez United States 8 163 0.9× 136 0.7× 72 0.5× 108 0.8× 188 2.6× 11 405
M.T. Allende Spain 12 132 0.7× 127 0.7× 109 0.8× 74 0.6× 20 0.3× 32 363
Jeffrey C. Goh Australia 11 109 0.6× 167 0.9× 91 0.6× 35 0.3× 167 2.3× 35 376

Countries citing papers authored by Stephanie Morrissey

Since Specialization
Citations

This map shows the geographic impact of Stephanie Morrissey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Morrissey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Morrissey more than expected).

Fields of papers citing papers by Stephanie Morrissey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Morrissey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Morrissey. The network helps show where Stephanie Morrissey may publish in the future.

Co-authorship network of co-authors of Stephanie Morrissey

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Morrissey. A scholar is included among the top collaborators of Stephanie Morrissey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Morrissey. Stephanie Morrissey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Liu, Joyce F., Niya Xiong, Susana M. Campos, et al.. (2021). Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma. Journal of Clinical Oncology. 39(14). 1531–1539. 115 indexed citations
2.
Lee, Elizabeth K., Niya Xiong, Su–Chun Cheng, et al.. (2020). Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial. Gynecologic Oncology. 159(1). 72–78. 64 indexed citations
3.
Liu, Joyce F., Niya Xiong, Susana M. Campos, et al.. (2020). A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma.. Journal of Clinical Oncology. 38(15_suppl). 6009–6009. 8 indexed citations
4.
Liu, Joyce F., Kathryn P. Gray, Alexi A. Wright, et al.. (2019). Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer. Gynecologic Oncology. 154(1). 95–101. 32 indexed citations
5.
Matulonis, Ursula A., Alexi A. Wright, Susana M. Campos, et al.. (2017). Abstract CT142: A single arm, single stage phase II trial of trametinib (GSK1120212) and GSK2141795 in persistent or recurrent cervical cancer. Cancer Research. 77(13_Supplement). CT142–CT142.
6.
7.
Matulonis, Ursula A., Alexi A. Wright, Susana M. Campos, et al.. (2015). A single arm, single stage phase II trial of trametinib (GSK1120212) and GSK2141795 in persistent or recurrent cervical cancer.. Journal of Clinical Oncology. 33(15_suppl). TPS5618–TPS5618. 1 indexed citations
8.
Choueiri, Toni K., Sumanta K. Pal, David F. McDermott, et al.. (2012). Efficacy of cabozantinib (XL184) in patients (pts) with metastatic, refractory renal cell carcinoma (RCC).. Journal of Clinical Oncology. 30(15_suppl). 4504–4504. 35 indexed citations
9.
Choueiri, Toni K., Sumanta K. Pal, David F. McDermott, et al.. (2012). Activity of cabozantinib (XL184) in patients (pts) with metastatic, refractory renal cell carcinoma (RCC).. Journal of Clinical Oncology. 30(5_suppl). 364–364. 13 indexed citations
10.
Morrissey, Stephanie, et al.. (2011). Management of Treatment-Related Toxicity with Targeted Therapies for Renal Cell Carcinoma: Evidence-Based Practice and Best Practices. Hematology/Oncology Clinics of North America. 25(4). 893–915. 18 indexed citations
11.
Choueiri, Toni K., Robert W. Ross, Susanna Jacobus, et al.. (2011). Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer. Journal of Clinical Oncology. 30(5). 507–512. 142 indexed citations
12.
Oh, William, Judith Manola, Daniel J. George, et al.. (2002). A Phase II Trial of Interferon-Alpha and Toremifene in Advanced Renal Cell Cancer Patients. Cancer Investigation. 20(2). 186–191. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C O'Flaherty Breakdown of academic impact, for papers by Christopher DiSimone Breakdown of academic impact, for papers by Domenico Priolo Breakdown of academic impact, for papers by Yasmine Baca Breakdown of academic impact, for papers by L. Cannella Breakdown of academic impact, for papers by S. Loibl Breakdown of academic impact, for papers by Josep M. del Campo Breakdown of academic impact, for papers by Angeles A. Alvarez Breakdown of academic impact, for papers by M.T. Allende Breakdown of academic impact, for papers by Jeffrey C. Goh
Rankless by CCL
2026